These Analysts Boost Their Forecasts On Tenet Healthcare After Upbeat Q2 Results

Benzinga

07/24

Tenet Healthcare Corporation (NYSE:THC) posted better-than-expected earnings for the second quarter on Tuesday.

The company reported quarterly earnings of $4.02 per share which beat the analyst consensus estimate of $2.87 per share. The company reported quarterly sales of $5.271 billion which beat the analyst consensus estimate of $5.161 billion.

The company raised its FY2025 adjusted EPS guidance from $11.99-$13.12 to $15.55-$16.21 and also increased its sales guidance from $20.600 billion-$21.000 billion to $20.950 billion-$21.250 billion.

“Our strong second quarter results extend our track record of attractive same store revenue growth, operational performance driven by fundamentals, and robust free cash flow generation,” said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. “We continue to make investments both organically and inorganically to expand our capabilities and innovate to better serve our patients.”

Tenet Healthcare shares rose 1% to trade at $157.49 on Wednesday.

These analysts made changes to their price targets on Tenet Healthcare following earnings announcement.

Guggenheim analyst Jason Cassorla maintained Tenet Healthcare with a Buy and raised the price target from $180 to $188.
Raymond James analyst John Ransom reiterated the stock with an Outperform rating and raised the price target from $185 to $200.

Considering buying THC stock? Here’s what analysts think:

Read This Next:

Wall Street’s Most Accurate Analysts Weigh In On 3 Industrials Stocks With Over 5% Dividend Yields

Photo via Shutterstock

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2553019244"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2553019244\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2553019244?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-24 01:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2553019244","market":"us","top_or_hot":-1,"title":"These Analysts Boost Their Forecasts On Tenet Healthcare After Upbeat Q2 Results","media":"Benzinga","content":"<html><body><p><strong><a href=\"https://laohu8.com/S/THC\">Tenet Healthcare</a> Corporation</strong> (<a href=\"https://laohu8.com/S/NYSE\">NYSE</a>:THC) posted better-than-expected earnings for the second quarter on Tuesday.</p>\n<p>The company reported quarterly earnings of $4.02 per share which beat the analyst consensus estimate of $2.87 per share. The company reported quarterly sales of $5.271 billion which beat the analyst consensus estimate of $5.161 billion.</p>\n<p>The company raised its FY2025 adjusted EPS guidance from $11.99-$13.12 to $15.55-$16.21 and also increased its sales guidance from $20.600 billion-$21.000 billion to $20.950 billion-$21.250 billion.</p>\n<p>“Our strong second quarter results extend our track record of attractive same store revenue growth, operational performance driven by fundamentals, and robust free cash flow generation,” said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. “We continue to make investments both organically and inorganically to expand our capabilities and innovate to better serve our patients.”</p>\n<p>Tenet <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> shares rose 1% to trade at $157.49 on Wednesday.</p>\n<p>These analysts made changes to their price targets on Tenet Healthcare following earnings announcement.</p>\n<ul>\n<li>Guggenheim analyst Jason Cassorla maintained Tenet Healthcare with a Buy and raised the price target from $180 to $188.</li>\n<li><a href=\"https://laohu8.com/S/RJF\">Raymond James</a> analyst John Ransom reiterated the stock with an Outperform rating and raised the price target from $185 to $200.</li>\n</ul>\n<p><strong>Considering buying THC stock? Here’s what analysts think:</strong> </p>\n<figure><img decoding=\"async\" height=\"551\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23132231/image-341-1024x551.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23132231/image-341-1024x551.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23132231/image-341-300x161.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23132231/image-341-768x413.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23132231/image-341.png 1098w\" width=\"1024\"/></figure>\n<p><strong>Read This Next: </strong></p>\n<ul>\n<li><strong>Wall Street’s Most Accurate Analysts Weigh In On 3 Industrials Stocks With Over 5% Dividend Yields</strong></li>\n</ul>\n<p>Photo via <a href=\"https://laohu8.com/S/SSTK\">Shutterstock</a></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These Analysts Boost Their Forecasts On Tenet Healthcare After Upbeat Q2 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese Analysts Boost Their Forecasts On Tenet Healthcare After Upbeat Q2 Results\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2025-07-24 01:24</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<html><body><p><strong><a href=\"https://laohu8.com/S/THC\">Tenet Healthcare</a> Corporation</strong> (<a href=\"https://laohu8.com/S/NYSE\">NYSE</a>:THC) posted better-than-expected earnings for the second quarter on Tuesday.</p>\n<p>The company reported quarterly earnings of $4.02 per share which beat the analyst consensus estimate of $2.87 per share. The company reported quarterly sales of $5.271 billion which beat the analyst consensus estimate of $5.161 billion.</p>\n<p>The company raised its FY2025 adjusted EPS guidance from $11.99-$13.12 to $15.55-$16.21 and also increased its sales guidance from $20.600 billion-$21.000 billion to $20.950 billion-$21.250 billion.</p>\n<p>“Our strong second quarter results extend our track record of attractive same store revenue growth, operational performance driven by fundamentals, and robust free cash flow generation,” said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. “We continue to make investments both organically and inorganically to expand our capabilities and innovate to better serve our patients.”</p>\n<p>Tenet <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> shares rose 1% to trade at $157.49 on Wednesday.</p>\n<p>These analysts made changes to their price targets on Tenet Healthcare following earnings announcement.</p>\n<ul>\n<li>Guggenheim analyst Jason Cassorla maintained Tenet Healthcare with a Buy and raised the price target from $180 to $188.</li>\n<li><a href=\"https://laohu8.com/S/RJF\">Raymond James</a> analyst John Ransom reiterated the stock with an Outperform rating and raised the price target from $185 to $200.</li>\n</ul>\n<p><strong>Considering buying THC stock? Here’s what analysts think:</strong> </p>\n<figure><img decoding=\"async\" height=\"551\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23132231/image-341-1024x551.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23132231/image-341-1024x551.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23132231/image-341-300x161.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23132231/image-341-768x413.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23132231/image-341.png 1098w\" width=\"1024\"/></figure>\n<p><strong>Read This Next: </strong></p>\n<ul>\n<li><strong>Wall Street’s Most Accurate Analysts Weigh In On 3 Industrials Stocks With Over 5% Dividend Yields</strong></li>\n</ul>\n<p>Photo via <a href=\"https://laohu8.com/S/SSTK\">Shutterstock</a></p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1201861165.SGD","symbol_name":"Natixis Harris Associates Global Equity PA SGD","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/25/07/46581222/these-analysts-boost-their-forecasts-on-tenet-healthcare-after-upbeat-q2-results","article_id":"2553019244","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2553019244","pubTimestamp":1753291449,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":" ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD","BK4185":"保健护理机构","THC":"泰尼特","LU0648000940.SGD":"Natixis Harris Associates Global Equity RA SGD","LU0130103400.USD":"Natixis Harris Associates Global Equity RA USD","LU0963586101.USD":"ALLIANZ GLOBAL SMALL CAP EQUITY \"AT\" ACC","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC"},"translate_title":"在第二季度业绩乐观后，这些分析师上调了对Tenet Healthcare的预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"THC":1},"content_text":"Tenet Healthcare Corporation (NYSE:THC) posted better-than-expected earnings for the second quarter on Tuesday.\nThe company reported quarterly earnings of $4.02 per share which beat the analyst consensus estimate of $2.87 per share. The company reported quarterly sales of $5.271 billion which beat the analyst consensus estimate of $5.161 billion.\nThe company raised its FY2025 adjusted EPS guidance from $11.99-$13.12 to $15.55-$16.21 and also increased its sales guidance from $20.600 billion-$21.000 billion to $20.950 billion-$21.250 billion.\n“Our strong second quarter results extend our track record of attractive same store revenue growth, operational performance driven by fundamentals, and robust free cash flow generation,” said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. “We continue to make investments both organically and inorganically to expand our capabilities and innovate to better serve our patients.”\nTenet Healthcare shares rose 1% to trade at $157.49 on Wednesday.\nThese analysts made changes to their price targets on Tenet Healthcare following earnings announcement.\n\nGuggenheim analyst Jason Cassorla maintained Tenet Healthcare with a Buy and raised the price target from $180 to $188.\nRaymond James analyst John Ransom reiterated the stock with an Outperform rating and raised the price target from $185 to $200.\n\nConsidering buying THC stock? Here’s what analysts think: \n\nRead This Next: \n\nWall Street’s Most Accurate Analysts Weigh In On 3 Industrials Stocks With Over 5% Dividend Yields\n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}